Lannett Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Lannett

Access the complete profile.

Lannett Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	9000 State Road Philadelphia, PA 19136

Lannett's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Lannett's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Lannett is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Lannett is a publicly traded company on NYQ using the ticker symbol LCI. Detailed information on company financials and operating reports can be found here: NYQ: LCI

Lannett Annual Revenue and Growth Rate

Lannett	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Lannett's revenues are gauged from an analysis of company filings.

Investor Activity

Lannett has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 7, 2021	22	N/A	$0 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Lannett is developing and marketing. Lannett doesn't have any recent trademark applications, indicating Lannett is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NUMBRINO Pharmaceutical preparations, namely, pre-surgical, surgical, and post-surgical topical anesthetic ointment, liquid and spray	04/18/2016
LCI [ Full line of ] pharmaceutical preparations and substances*, namely, analgesic preparations*	06/29/2010
LANNETT FULL LINE OF PHARMACEUTICAL PREPARATIONS AND SUBSTANCES	10/12/2001

See all trademarks and details in the Full Report.

Market Share of Lannett's Largest Competitors

A competitive analysis shows these companies are in the same general field as Lannett, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Lannett. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GLAXOSMITHKLINE	Philadelphia, PA	100
AKORN OPERATING COMPANY LLC DBA AKORN	Philidelphia, PA	6
LANNETT	Philadelphia, PA	4
ADAPTIMMUNE	Philadelphia, PA	3
FRONTIDA BIOPHARM	Philadelphia, PA	2
VINTA BIO	Philadelphia, PA	1

Future Competition: Lannett's Fastest Growing Competitors

These companies are in the same general field as Lannett and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)